EP0802787A4 - VECTEUR D'APPORT DE SUBSTANCES BIO-EFFICACES A GELIFICATION -i(IN SITU) ET METHODE D'UTILISATION - Google Patents

VECTEUR D'APPORT DE SUBSTANCES BIO-EFFICACES A GELIFICATION -i(IN SITU) ET METHODE D'UTILISATION

Info

Publication number
EP0802787A4
EP0802787A4 EP95921627A EP95921627A EP0802787A4 EP 0802787 A4 EP0802787 A4 EP 0802787A4 EP 95921627 A EP95921627 A EP 95921627A EP 95921627 A EP95921627 A EP 95921627A EP 0802787 A4 EP0802787 A4 EP 0802787A4
Authority
EP
European Patent Office
Prior art keywords
bio
delivery vehicle
situ gel
affecting substances
forming delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP95921627A
Other languages
German (de)
English (en)
Other versions
EP0802787A1 (fr
Inventor
Kenneth J Himmelstein
Bert O Haglund
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Nebraska
Original Assignee
University of Nebraska
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Nebraska filed Critical University of Nebraska
Publication of EP0802787A1 publication Critical patent/EP0802787A1/fr
Publication of EP0802787A4 publication Critical patent/EP0802787A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
EP95921627A 1994-06-17 1995-06-09 VECTEUR D'APPORT DE SUBSTANCES BIO-EFFICACES A GELIFICATION -i(IN SITU) ET METHODE D'UTILISATION Withdrawn EP0802787A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26173194A 1994-06-17 1994-06-17
US261731 1994-06-17
PCT/US1995/007333 WO1995035093A1 (fr) 1994-06-17 1995-06-09 Vecteur d'apport de substances bio-efficaces a gelification in situ et methode d'utilisation

Publications (2)

Publication Number Publication Date
EP0802787A1 EP0802787A1 (fr) 1997-10-29
EP0802787A4 true EP0802787A4 (fr) 1998-09-02

Family

ID=22994617

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95921627A Withdrawn EP0802787A4 (fr) 1994-06-17 1995-06-09 VECTEUR D'APPORT DE SUBSTANCES BIO-EFFICACES A GELIFICATION -i(IN SITU) ET METHODE D'UTILISATION

Country Status (5)

Country Link
EP (1) EP0802787A4 (fr)
JP (1) JPH10501814A (fr)
AU (1) AU2638795A (fr)
CA (1) CA2192708A1 (fr)
WO (1) WO1995035093A1 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2737406B1 (fr) † 1995-08-04 1997-10-24 Sederma Sa Gel a activite physique pour produits cosmetiques
US20020064546A1 (en) 1996-09-13 2002-05-30 J. Milton Harris Degradable poly(ethylene glycol) hydrogels with controlled half-life and precursors therefor
US6258351B1 (en) 1996-11-06 2001-07-10 Shearwater Corporation Delivery of poly(ethylene glycol)-modified molecules from degradable hydrogels
DE19701912C1 (de) * 1997-01-10 1998-05-14 Jenapharm Gmbh Injizierbares Implantat
US6596291B2 (en) * 1997-12-05 2003-07-22 Thomas A. Bell Compositions and methods for treating surfaces infected with ectoparasitic insects
KR20010099975A (ko) * 1998-12-28 2001-11-09 우에하라 아끼라 외용제
AU4977800A (en) * 1999-04-26 2000-11-10 California Institute Of Technology (in situ) forming hydrogels
EP1411916B1 (fr) 2001-07-09 2008-08-27 Repros Therapeutics Inc. Methodes et materiaux destines au traitement de la deficience en testosterone chez l'homme
US7173064B2 (en) 2001-07-09 2007-02-06 Repros Therapeutics Inc. Methods and compositions with trans-clomiphene for treating wasting and lipodystrophy
US7737185B2 (en) 2001-07-09 2010-06-15 Repros Therapeutics Inc. Methods and compositions with trans-clomiphene
SE0302509D0 (sv) * 2003-09-19 2003-09-19 Amersham Biosciences Ab Matrix for separation of polyethers and method of separation
RU2404757C2 (ru) 2005-02-04 2010-11-27 Репрос Терапьютикс Инк. Способы и материалы с транс-кломифеном для лечения мужского бесплодия
AU2006227243B2 (en) 2005-03-22 2011-10-27 Allergan pharmaceuticals International Ltd. Dosing regimes for trans-clomiphene
CA2806526C (fr) 2007-10-16 2014-12-30 Repros Therapeutics Inc. Trans-clomiphene pour le diabete de type 2
UA113291C2 (xx) 2011-08-04 2017-01-10 Метаболіти транскломіфену і їх застосування
MX2015005160A (es) 2012-11-02 2015-07-17 Repros Therapeutics Inc Trans-clomifeno para uso en terapia de cancer.
WO2016170531A1 (fr) * 2015-04-20 2016-10-27 Botanocap Ltd. Microcapsules à noyau liquide et solide formées par complexation interpolymérique
WO2020033677A1 (fr) 2018-08-08 2020-02-13 Johnson Lanny Leo Méthodes de diagnostic et de traitement d'implants infectés

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *
See also references of WO9535093A1 *

Also Published As

Publication number Publication date
WO1995035093A1 (fr) 1995-12-28
EP0802787A1 (fr) 1997-10-29
CA2192708A1 (fr) 1995-12-28
AU2638795A (en) 1996-01-15
JPH10501814A (ja) 1998-02-17

Similar Documents

Publication Publication Date Title
EP0802787A4 (fr) VECTEUR D'APPORT DE SUBSTANCES BIO-EFFICACES A GELIFICATION -i(IN SITU) ET METHODE D'UTILISATION
EP0776215A4 (fr) Dispositif d'administration de substances et ses modes d'utilisation
EP0764082A4 (fr) Composition odorante, son procede et systeme de liberation
EP0956091A4 (fr) Appareil d'administration de medicaments iontophoretiques, et methode d'utilisation
PL321011A1 (en) Method and apparatus for use in satellite communication
AUPN724095A0 (en) Method and apparatus for the application of volatile substances conveyed in carrier gas
PL320565A1 (en) Substances and their application
AP9901599A0 (en) Biologically active substances method for obtaining and compositions containing them
GB2286613B (en) Improvements in or relating to methods and apparatus for improving the condition of ground
EP0794769A4 (fr) Procede d'apport medicamenteux et enrobages utilises selon ce procede
EP0783465A4 (fr) Composition d'argile activee et procede associe
GB9517708D0 (en) Irrigation processes and polymeric materials for use in these
EP1027098A4 (fr) Substance electriquement activee et son procede de fabrication
GB9604273D0 (en) Material dosing method and apparatus
AU2702595A (en) Method and apparatus for in situ soil remediation
GB9724240D0 (en) Method and apparatus for use of gases in liquid
ZA984264B (en) Apparatus and method for treating the atmosphere contained in enclosed spaces
GB2319326B (en) Dosing apparatus and method
GB9615497D0 (en) Materials for use in oils and processes for their manufacture
GB9417088D0 (en) Test method and materials for use therein
EP1021588A4 (fr) Procede et appareil d'administration de fluide
GB9720685D0 (en) Method and device for maintaining vehicles
GB2354307B (en) Dosing apparatus and method
GB8907608D0 (en) Method of spreading and vehicle for use in the method
AUPM507994A0 (en) Liquid delivery apparatus and method

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19961216

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 19980722

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19981009